Journal profile
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
ISSN 2406-9388 · eISSN 2580-8303 · Faculty of Pharmacy, Universitas Airlangga · Indonesia
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia: diamond open access (no APC); no APC; review about 12 weeks (community reports); 40 articles in 2025.
Scope
Aims, scope and focus
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia is published by Faculty of Pharmacy, Universitas Airlangga. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Pharmacy and Medical Practices and Advancements in Transdermal Drug Delivery, together about 31.8% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia (JFIKI) limits scientific articles to the scopes: 1. Clinical Pharmacy 2. Pharmaceutical Chemistry 3. Pharmaceutics 4. Community Pharmacy 5. Pharmacognosy
From the journal's Aims & Scope
Editor-in-chief Elida Zairina, S.Si., MPH., Ph.D., Apt.Publisher website
Editorial board by country: none in mainland China; most named Indonesia 18, Malaysia 2, Thailand 2, United States 1, Sweden 1 (26 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences13.6%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics9.6%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics8.6%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.6%
- Computational Drug Discovery MethodsComputer Science5.1%
- Skin Protection and AgingMedicine5.1%
- Pharmaceutical Practices and Patient OutcomesMedicine4.3%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Sinta 2, Dimensions, EBSCOPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 13OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 0.48OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 301 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 25 | 119 |
| 2025 | 40 | 40 | 130 |
| 2024 | 38 | 38 | 154 |
| 2023 | 40 | 40 | 214 |
| 2022 | 39 | 39 | 149 |
| 2021 | 48 | 48 | 75 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Reference style
- APA
- First submission
- Free format: the journal's layout is not required
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted3
- meta analysisJurnal Farmasi dan Ilmu Kefarmasian Indonesia (Pharmacy and Pharmaceutical Sciences Journal) receives manuscript from the results of research (research article)…Length not stated
- research articleJurnal Farmasi dan Ilmu Kefarmasian Indonesia (Pharmacy and Pharmaceutical Sciences Journal) receives manuscript from the results of research (research article)…Length not stated
- systematic reviewJurnal Farmasi dan Ilmu Kefarmasian Indonesia (Pharmacy and Pharmaceutical Sciences Journal) receives manuscript from the results of research (research article)…Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review, Plagiarism
- License & copyright Copyright Notice
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License Model summary
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author. 2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes …
Source ↗Publisher website ·- Open access Open Access Policy
Open access journal Model summary
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. JFIKI is an open access journal.
Source ↗Publisher website ·- Peer review Peer Review Process
Closed (double-blind) peer review process Model summary
Submitted manuscripts on Jurnal Farmasi dan Ilmu Kefarmasian Indonesia (JFIKI) will go through the administration review and editor review stages before it will be sent to the reviewers. At the administrative review stage, checks will be made whether the submitted manuscripts comply with the rules that apply to the JFIKI author guidelines and templates. The complete files or supporting files for s…
Source ↗Publisher website ·- Plagiarism Plagiarism Screening
All the submitted manuscripts are checked for plagiarism before starting the review process. Plagiarism is not acceptable in JFIKI. We uses "turnitin” software for the plagiarism check.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Faculty of Pharmacy, Universitas Airlangga
- Country or region
- Indonesia
- Language
- Indonesian
- ISSN
- 2406-9388
- Electronic ISSN
- 2580-8303
- Latest issue on the website
- Volume 13, Issue 2 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
How long does peer review take at Jurnal Farmasi dan Ilmu Kefarmasian Indonesia?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Jurnal Farmasi dan Ilmu Kefarmasian Indonesia?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Reference style: APA; First submission: Free format: the journal's layout is not required; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Jurnal Farmasi dan Ilmu Kefarmasian Indonesia based?
Of the 26 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Indonesia (18), Malaysia (2) and Thailand (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Jurnal Farmasi dan Ilmu Kefarmasian Indonesia?
According to LetPub and DOAJ records, Jurnal Farmasi dan Ilmu Kefarmasian Indonesia is indexed in DOAJ.
Is Jurnal Farmasi dan Ilmu Kefarmasian Indonesia open access, and what is the APC?
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .